59 related articles for article (PubMed ID: 52365)
21. [Aminophenazone half life in patients with chronic liver parenchyma disorders].
Ackermann E; Renger F; Dökert B; Walther M
Z Gesamte Inn Med; 1972 Oct; 27(19):849-53. PubMed ID: 4647370
[No Abstract] [Full Text] [Related]
22. [Comparison of pharmacokinetics of the combination trimethoprim and sulfamethoxazole in patients with liver diseases and healthy persons].
Rieder VJ; Schwartz DE
Arzneimittelforschung; 1975 Apr; 25(4):656-66. PubMed ID: 1174084
[TBL] [Abstract][Full Text] [Related]
23. Prednisolone succinate and prednisolone acetate in cattle: pharmacokinetics and action on the adrenal gland.
Toutain PL; Koritz GD; Alvinerie M; de Pomyers H; Ruckebusch Y
Am J Vet Res; 1985 Mar; 46(3):719-25. PubMed ID: 3994138
[TBL] [Abstract][Full Text] [Related]
24. [Results of oral methionine loads in normal subjects and patients with liver diseases using an analyzer short program].
Peters WH; Lubs H; Knoke M; Zschiesche M
Acta Biol Med Ger; 1977; 36(10):1435-43. PubMed ID: 616159
[TBL] [Abstract][Full Text] [Related]
25. [Elimination of 75Se-selenmethionine from the plasma of patients with liver disorders (author's transl)].
Pirwitz B
Przegl Lek; 1979; 36(7):573-6. PubMed ID: 504707
[No Abstract] [Full Text] [Related]
26. [Pharmacokinetics of midazolam after i.v. administration (author's transl)].
Amrein R; Cano JP; Eckert M; Coassolo P
Arzneimittelforschung; 1981; 31(12a):2202-5. PubMed ID: 7199322
[TBL] [Abstract][Full Text] [Related]
27. [Metabolism of phenylbutazone in the liver (author's transl)].
González Macías J; De Castro del Pozo S
Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107
[TBL] [Abstract][Full Text] [Related]
28. Corticosteroid therapy augments gastroduodenal permeability to sucrose.
Kiziltaş S; Imeryüz N; Gürcan T; Siva A; Saip S; Dumankar A; Kalayci C; Ulusoy NB
Am J Gastroenterol; 1998 Dec; 93(12):2420-5. PubMed ID: 9860402
[TBL] [Abstract][Full Text] [Related]
29. [Plasmapheresis and hormone therapy in severe forms of Guillain-Barré syndrome].
Levchenko NI; Piradov MA; Pirogov VN
Klin Med (Mosk); 1989 Dec; 67(12):88-91. PubMed ID: 2560799
[TBL] [Abstract][Full Text] [Related]
30. [Biotransformation of prednisone to prednisolone in patients with liver cirrhosis].
Madsbad S; Bjerregaard B; Henriksen JH; Juhl E; Kehlet H
Ugeskr Laeger; 1979 May; 141(20):1325-8. PubMed ID: 452141
[No Abstract] [Full Text] [Related]
31. Variability of caffeine metabolism in humans.
Kalow W
Arzneimittelforschung; 1985; 35(1A):319-24. PubMed ID: 3838675
[TBL] [Abstract][Full Text] [Related]
32. Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure.
Kawai S; Ichikawa Y; Homma M
J Clin Endocrinol Metab; 1985 May; 60(5):848-54. PubMed ID: 3980669
[TBL] [Abstract][Full Text] [Related]
33. [Metabolism of synthetic corticosteroid esters in man (author's transl)].
Miyabo S; Hisada T; Kishida S; Asato T
Nihon Naibunpi Gakkai Zasshi; 1976 Oct; 52(10):997-1007. PubMed ID: 1035169
[TBL] [Abstract][Full Text] [Related]
34. Studies on the pharmacokinetics and metabolism of prednicarbate after cutaneous and oral administration.
Barth J; Lehr KH; Derendorf H; Möllmann HW; Höhler T; Hochhaus G
Skin Pharmacol; 1993; 6(3):179-86. PubMed ID: 8274287
[TBL] [Abstract][Full Text] [Related]
35. Measurements of prednisolone and some of its metabolites, in urine of patients after orthotopic liver transplantation, as a means of monitoring prednisolone absorption.
Koopman BJ; van der Molen JC; Haagsma EB; Huizenga JR; Krom RA; Nagel GT; Gips CH; Wolthers BG
J Clin Chem Clin Biochem; 1986 Nov; 24(11):831-9. PubMed ID: 3543199
[TBL] [Abstract][Full Text] [Related]
36. Profile of the urinary excretion of prednisolone and its metabolites in finishing bulls and cows treated with a therapeutic schedule.
Nebbia C; Capra P; Leporati M; Girolami F; Barbarino G; Gatto S; Vincenti M
BMC Vet Res; 2014 Sep; 10():237. PubMed ID: 25267433
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous measurement of prednisone, prednisolone and 6 beta-hydroxyprednisolone in urine by high-performance liquid chromatography coupled with a radioactivity detector.
Frey BM; Frey FJ
J Chromatogr; 1982 May; 229(2):283-92. PubMed ID: 7096466
[TBL] [Abstract][Full Text] [Related]
38. Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects.
Kozower M; Veatch L; Kaplan MM
J Clin Endocrinol Metab; 1974 Mar; 38(3):407-12. PubMed ID: 4815171
[No Abstract] [Full Text] [Related]
39. [Metabolism of synthetic glucocorticoids].
Takeda R; Saito Z
Nihon Rinsho; 1979 Jun; 37(6):1193-8. PubMed ID: 480651
[No Abstract] [Full Text] [Related]
40. The impact of stress on the prevalence of prednisolone in bovine urine: A metabolic fingerprinting approach.
De Clercq N; Van Meulebroek L; Vanden Bussche J; Croubels S; Delahaut P; Vanhaecke L
J Steroid Biochem Mol Biol; 2015 Nov; 154():206-16. PubMed ID: 26321385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
